Early Adjuvant Therapy Links to Better Survival in Esophageal Cancer Study
Initiating postoperative chemoimmunotherapy within 56 days of esophagectomy was associated with improved disease-free and overall survival in esophageal cancer patients.
Initiating postoperative chemoimmunotherapy within 56 days of esophagectomy was associated with improved disease-free and overall survival in esophageal cancer patients.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.